Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05579938 · ClinicalTrials.gov registry record · NA

Effect of Enzymes on Dental Biofilm Accumulation

A NA study of Dental Plaque, sponsored by Novozymes A/S.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT05579938 is a NA study of Dental Plaque that has completed, run by Novozymes A/S. The registered enrollment target is 28 participants, below the 622-participant average among 10 other Dental Plaque trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05579938, a NA study of Dental Plaque, has completed, sponsored by Novozymes A/S.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

Double-blind, placebo-controlled, cross-over study investigating dental biofilm accumulation after 4-days in 28 subjects randomised to receive: Sequence 1: 5 active enzyme-containing lozenges per day for 4-days followed by a 2-week washout period followed by 5 identical placebo lozenges per day for 4-days or Sequence 2: 5 placebo lozenges per day for 4-days followed by a 2-week washout period followed by 5 identical active enzyme lozenges per day for 4-days

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Enzyme-containing lozenge
  • DIETARY_SUPPLEMENT Placebo lozenge

Study Locations (1)

Indiana

  • Salus Research Inc - Fort Wayne

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2022-09-19
Est. Completion 2022-11-20
Phase NA

Sponsor

Novozymes A/S

5 total trials

What the Registry Record Tells You About NCT05579938

The ClinicalTrials.gov registry entry for NCT05579938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 622-participant average among 10 other Dental Plaque trials with a reported enrollment target (95% lower). The listed sponsor is Novozymes A/S, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Plaque appearing as the primary indexed condition, and to 2 interventions - of which Enzyme-containing lozenge is the first listed.

NCT05579938 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05579938 about?

NCT05579938 is a clinical study titled "Effect of Enzymes on Dental Biofilm Accumulation". Double-blind, placebo-controlled, cross-over study investigating dental biofilm accumulation after 4-days in 28 subjects randomised to receive: Sequence 1: 5 active enzyme-containing lozenges per day for 4-days followed by a 2-week washout period followed by 5 identical placebo lozenges per day for...

What is the current status of trial NCT05579938?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-09-19. Estimated completion is 2022-11-20.

What conditions does trial NCT05579938 study?

This clinical trial studies the following conditions: Dental Plaque.

What interventions are being tested in trial NCT05579938?

The interventions under investigation include: Enzyme-containing lozenge (DIETARY_SUPPLEMENT), Placebo lozenge (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05579938?

This trial is sponsored by Novozymes A/S, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05579938 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Plaque

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.